Hantech Bio-Technology Co., Ltd.

TPEX:1294 Stock Report

Market Cap: NT$2.4b

Hantech Bio-Technology Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Yulin Li

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.8yrs
CEO ownershipn/a
Management average tenure2.8yrs
Board average tenure4.2yrs

Recent management updates

Recent updates

CEO

Yulin Li

2.8yrs
Tenure

Mr. Yulin Li serves as GM & Chairman of Hantech Bio-Technology Co., Ltd..

Leadership Team

NamePositionTenureCompensationOwnership
Yulin Li
GM & Chairman2.8yrsno datano data
Qihao Liu
CFO & Treasurer6.3yrsno datano data
Laien Li
Deputy GM of General Administration Office2.8yrsno datano data
Yuxuan Li
Chief of Audit Section2.8yrsno datano data
Bizhen Yang
Deputy GM of Quality Assurance Department9.1yrsno datano data
2.8yrs
Average Tenure

Experienced Management: 1294's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yulin Li
GM & Chairman13.8yrsno datano data
Meijuan Yang
Director4.2yrsno datano data
Kin Wang Chan
Director6.3yrsno datano data
Zhenzhi Huang
Director8.2yrsno datano data
Shangwen Hong
Director9.3yrsno datano data
Qinglong Xie
Independent Director4.2yrsno datano data
Yuqi Wang
Independent Director4.2yrsno datano data
Chonggui Chen
Director4.2yrsno datano data
Jiancheng Zhu
Independent Director4.2yrsno datano data
4.2yrs
Average Tenure

Experienced Board: 1294's board of directors are considered experienced (4.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/05 16:16
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hantech Bio-Technology Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hsiu Chi LinMasterlink Securities Corp.
Kyeongkeun KangNH Investment & Securities Co., Ltd.